Evidence map›Paper›PMID 15194758›Full record

ArticleJournal of virology2004

An optimized CD4 T-cell response can control productive and latent gammaherpesvirus infection.

Rebecca L Sparks-Thissen, Douglas C Braaten, Scott Kreher, Samuel H Speck, Herbert W Virgin

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. CD4 CTL: living up to the challenge.Seminars in immunology · 2013
    Review
  12. Article
  13. Review
  14. Murine gammaherpesvirus 68 infection protects lupus-prone mice from the development of autoimmunity.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Rebecca L Sparks-ThissenDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Douglas C Braaten
Scott Kreher
Samuel H Speck
Herbert W Virgin
Washington University in St. Louis · US

Funding

Infectious Diseases/Basic Microbial Pathogenic MechanismsT32AI007172 · NIAID · WASHINGTON UNIVERSITY · PI Daniel E. Goldberg, JENNIFER A PHILIPS · 1985 to 2026
$13.0M
TRAINING IN THE IMMUNOBIOLOGY AND MOLECULAR CELL BIOLOGY OF CANCERT32CA009547 · NCI · WASHINGTON UNIVERSITY · PI ROBERT DAVID SCHREIBER · 1986 to 2026
$12.1M
T Cell Vaccination Against gamma-herpesvirus LatencyR01CA096511 · NCI · WASHINGTON UNIVERSITY · PI VIRGIN, HERBERT W · 2002 to 2012
$2.4M
NCI NIH HHS R01 CA096511NCI NIH HHS R01 CA96511NCI NIH HHS T32 CA009547NCI NIH HHS T32 CA09547NIAID NIH HHS T32 AI07172
6 · The paper itself

Abstract

CD4 T cells are important for control of infection with murine gammaherpesvirus 68 (gamma HV68), but it is not known whether CD4 T cells function via provision of help to other lymphocyte subsets, such as B cells and CD8 T cells, or have an independent antiviral function. Moreover, under conditions of natural infection, the CD4 T-cell response is not sufficient to eliminate infection. To determine the functional capacities of CD4 T cells under optimal or near-optimal conditions and to determine whether CD4 T cells can control gamma HV68 infection in the absence of CD8 T cells or B cells, we studied the effect of ovalbumin (OVA)-specific CD4 T cells on infection with a recombinant gamma HV68 that expresses OVA. OVA-specific CD4 T cells limited acute gamma HV68 replication and prolonged the life of infected T-cell receptor-transgenic RAG (DO.11.10/RAG) mice, demonstrating CD4 T-cell antiviral activity, independent of CD8 T cells and B cells. Despite CD4 T-cell-mediated control of acute infection, latent infection was established in DO.11.10/RAG mice. However, OVA-specific CD4 T cells reduced the frequency of latently infected cells both early (16 days postinfection) and late (42 days postinfection) after infection of mice containing CD8 T cells and B cells (DO.11.10 mice). These results show that OVA-specific CD4 T cells have B-cell and CD8 T-cell-independent antiviral functions in the control of acute infection and can, in the absence of preexisting CD8 T-cell or B-cell immunity, inhibit the establishment of gammaherpesvirus latency.

Indexed as

Lymphocyte ActivationVirus LatencyAnimalsB-LymphocytesCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesGammaherpesvirinaeHerpesviridae InfectionsMiceMice, Inbred BALB CMice, Inbred C57BLMice, KnockoutOvalbuminOvalbumin

Identifiers

PMID15194758
PMCPMC421646
OpenAlexW4232631624

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.